Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update on smallpox vaccines].

D Garin1, J M Crance, F Fuchs

  • 1Laboratoire de virologie, CRSSA Emile-Pardé, BP 87, 38702 Grenoble cedex, France. daniel.garin@wanadoo.fr

Medecine Et Maladies Infectieuses
|December 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Alterations in responses to vaccines in older people].

Revue des maladies respiratoires·2019
Same author

PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.

EBioMedicine·2017
Same author

Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

New diketopiperazines as vectors for peptide protection and brain delivery: Synthesis and biological evaluation.

Journal of labelled compounds & radiopharmaceuticals·2016
Same author

[Biological follow-up of patients with HIV treated with anti-PD-1 or anti-PD-L1 for non-small cell bronchial carcinoma: A task group proposal].

Revue des maladies respiratoires·2016
Same journal

[Etiology and clinical expression of angina].

Medecine et maladies infectieuses·2024
Same journal

[Rational use of antibiotics treatment in acute bronchitis].

Medecine et maladies infectieuses·2024
Same journal

Medecine et maladies infectieuses·2024
Same journal

[Detection of human rotaviruses in faeces : comparison of five methods].

Medecine et maladies infectieuses·2024
Same journal

Medecine et maladies infectieuses·2024
Same journal

Medecine et maladies infectieuses·2024
See all related articles

Smallpox poses a significant bioterrorism threat. Current vaccines should be replaced by advanced cell-cultured and non-replicative viral strain vaccines for enhanced safety and efficacy.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Context:

  • Smallpox virus is a high-consequence pathogen with bioterrorism potential.
  • Traditional vaccines, while effective, have limitations and safety concerns.
  • The need for improved smallpox countermeasures is critical.

Purpose:

  • To review the limitations of current smallpox vaccines.
  • To advocate for the adoption of next-generation vaccines.
  • To discuss the transition to safer vaccine technologies.

Summary:

  • Smallpox virus remains a major bioterrorism concern.
  • Existing vaccines, produced via animal scarification, require modernization.
  • Cell-cultured (second-generation) and non-replicative viral strain (third-generation) vaccines offer improved safety and scalability.

Related Experiment Videos

Impact:

  • Transitioning to advanced vaccines will enhance national biodefense capabilities.
  • Safer vaccines will reduce adverse events and improve public health preparedness.
  • The development of novel vaccines is crucial for future smallpox eradication and control efforts.